Manolya

Bitki adı: Magnolia / trunk bark, magnolia bark extract
Bilimsel adı: Magnolia officinalis
Cins: Magnolia
Familya: Magnoliaceae
Diğer adları: Magnolia / trunk bark, magnolia bark extract

Magnolia officinalis

Genel Bilgiler


Duke – Ethnobotany

Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Li
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Li
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Hunan
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Li
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Nas
Kaynak: James A. Duke
Bilgi: Duke USEAGE: M | Keys
Kaynak: James A. Duke

Bilimsel Araştırmalar

SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths. There are currently no registered therapies for treating coronavirus infections. Because of time consuming process of new drug development, drug repositioning may be the only solution to the epidemic of sudden infectious diseases. We systematically analyzed all the proteins encoded by SARS-CoV-2 genes, compared them with proteins from other coronaviruses, predicted their structures, and built 19 structures that could be done by homology modeling. By performing target-based virtual ligand screening, a total of 21 targets (including two human targets) were screened against compound libraries including ZINC drug database and our own database of natural products. Structure and screening results of important targets such as 3-chymotrypsin-like protease (3CLpro), Spike, RNA-dependent RNA polymerase (RdRp), and papain like protease (PLpro) were discussed in detail. In addition, a database of 78 commonly used anti-viral drugs including those currently on the market and undergoing clinical trials for SARS-CoV-2 was constructed. Possible targets of these compounds and potential drugs acting on a certain target were predicted. This study will provide new lead compounds and targets for further in vitro and in vivo studies of SARS-CoV-2, new insights for those drugs currently ongoing clinical studies, and also possible new strategies for drug repositioning to treat SARS-CoV-2 infections.

Makaleyi görüntüle
In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named "2019 novel coronavirus (2019-nCoV)" by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world's attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.

Makaleyi görüntüle
Oxygen-derived free radicals, collectively termed reactive oxygen species (ROS), play important roles in immunity, cell growth, and cell signaling. In excess, however, ROS are lethal to cells, and the overproduction of these molecules leads to a myriad of devastating diseases. The key producers of ROS in many cells are the NOX family of NADPH oxidases, of which there are seven members, with various tissue distributions and activation mechanisms. NADPH oxidase is a multisubunit enzyme comprising membrane and cytosolic components, which actively communicate during the host responses to a wide variety of stimuli, including viral and bacterial infections. This enzymatic complex has been implicated in many functions ranging from host defense to cellular signaling and the regulation of gene expression. NOX deficiency might lead to immunosuppression, while the intracellular accumulation of ROS results in the inhibition of viral propagation and apoptosis. However, excess ROS production causes cellular stress, leading to various lethal diseases, including autoimmune diseases and cancer. During the later stages of injury, NOX promotes tissue repair through the induction of angiogenesis and cell proliferation. Therefore, a complete understanding of the function of NOX is important to direct the role of this enzyme towards host defense and tissue repair or increase resistance to stress in a timely and disease-specific manner.

Makaleyi görüntüle
Cancer prevention and treatment using traditional Chinese medicines have attracted increasing interest. This study characterizes antioxidant activity and phenolic compounds of traditional Chinese medicinal plants associated with anticancer, comprising 112 species from 50 plant families. The improved ABTS(*+) method was used to systematically assess the total antioxidant capacity (Trolox equivalent antioxidant capacity, TEAC) of the medicinal extracts. The TEAC values and total phenolic content for methanolic extracts of herbs ranged from 46.7 to 17,323 micromol Trolox equivalent/100 g dry weight (DW), and from 0.22 to 50.3 g of gallic acid equivalent/100 g DW, respectively. A positive, significant linear relationship between antioxidant activity and total phenolic content (all R(2) values>/=0.95) showed that phenolic compounds were the dominant antioxidant components in the tested medicinal herbs. Major types of phenolic compounds from most of the tested herbs were preliminarily identified and analyzed, and mainly included phenolic acids, flavonoids, tannins, coumarins, lignans, quinones, stilbenes, and curcuminoids. These medicinal herbs exhibited far stronger antioxidant activity and contained significantly higher levels of phenolics than common vegetables and fruits. Traditional Chinese medicinal plants associated with anticancer might be potential sources of potent natural antioxidants and beneficial chemopreventive agents.

Makaleyi görüntüle
Two similar cases of rapidly progressive fibrosing interstitial nephritis in young women who followed the same slimming regimen prompted us to conduct an epidemiological survey of the nephrology centres of Brussels and to further investigate the exact nature of this slimming treatment. Seven other women under the age of 50 in terminal or preterminal renal failure were admitted for dialysis in 1991 and 1992. They had all followed a slimming regimen in the same medical clinic. Renal biopsy samples in eight of the nine cases showed extensive interstitial fibrosis without glomerular lesions. Two of the patients were seen for the first time in terminal renal failure and were started immediately on dialysis. For the seven other women, the nephropathy was characterised by a rapid deterioration in renal function, with initial serum creatinine doubling within about 3 months. The clinic had specialised in slimming treatments for the previous 15 years without any problems. In May, 1990, therapy was changed, with the introduction of two Chinese herbs (Stephania tetrandra and Magnolia officinalis). In June, 1992, three of twenty-five randomly selected women who had followed the same regimen during at least 3 months from 1990 had impaired renal function. Chemical analysis of some brands of these Chinese herbs did not show nephrotoxic contaminants of fungal or plant origin (ochratoxin or aristolochic acid) or adulteration by diuretics or antiinflammatory drugs. However, the medicinal preparation of the capsules taken by patients had different alkaloid profiles from those expected in Chinese plants. The striking relation between a specific type of fibrosing interstitial nephritis in young women and a slimming treatment involving Chinese herbs adds support to the arguments against uncontrolled therapy with herbal preparations.

Makaleyi görüntüle

Kaynaklar ve Görseller

« Magnolia obovata Magnolia ovata »